IP Library Granted Patent US 12,037,622
Granted Patent B2
US 12,037,622 · App. 17/323,737 · Granted Jul 16, 2024

Production of human milk oligosaccharides in microbial hosts with engineered import / export

Inventors: Stefan Jennewein (Bad Honnef, DE); Dirk Wartenberg (Bonn, DE)
Assignee: Chr. Hansen HMO GmbH
C12P19/18C12N9/1051C12N15/70C12Y204/01146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,037,622
App. No.
17/323,737
Granted
Jul 16, 2024
Kind
B2
Abstract

The present invention relates to methods for the production of oligosaccharides in genetically modified bacterial host cells, as well as to the genetically modified host cells used in the methods. The genetically modified host cell comprises at least one recombinant glycosyltransferase, and at least one nucleic acid sequence coding for a protein enabling the export of the oligosaccharide.

Claims (9)

1. A method for the production of lacto-N-triose II by a genetically modified microbial host cell, comprising

providing a genetically modified microbial host cell that comprises:

at least one recombinant β-1,3-N-acetylglucosaminyltransferase, wherein the at least one recombinant β-1,3-N-acetylglucosaminyltransferase belongs to the class of lgtA of Neisseria meningitidis , and

increased expression of at least one sugar export protein capable of exporting the lacto-N-triose II, wherein the at least one sugar export protein is SetA from Cedecea neteri;

cultivating the microbial host cell in a medium under conditions permissive for the production of the lacto-N-triose II, whereby the lacto-N-triose II is exported into the medium at an increased level compared to the unmodified microbial host cell, and

obtaining the lacto-N-triose II from the medium.

2. A genetically modified microbial host cell for the production of lacto-N-triose II, wherein the microbial host cell comprises:

at least one recombinant β-1,3-N-acetylglucosaminyltransferase, wherein the at least one recombinant β-1,3-N-acetylglucosaminyltransferase belongs to the class of lgtA of Neisseria meningitidis , and

increased expression of at least one sugar export protein capable of exporting the lacto-N-triose II, wherein the at least one sugar export protein is SetA from Cedecea neteri.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Apr 6, 2022
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 059617/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: JENNEWEIN, STEFAN; WARTENBERG, DIRK
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 056366/0707 →
Priority Claims (1)
EP 15184968 · Sep 12, 2015 · regional
Continuity (2)
Division 15758653
Related Publication 20210277435A1 · Sep 9, 2021